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Abstract
Brucellosis is a zoonotic infectious disease caused by the Brucella bacteria. 
Neonatal brucellosis is very rare and preventable and is an example of intrauterine 
infection, but clinical manifestations as well as transmission route are not well 
defined but presumed transplacental transmission. The neonate can be either 
infected transplacentally, or by ingestion of mother’s secretions and blood during 
delivery, or by ingestion of breast milk. Presentation of the neonatal brucellosis 
including fever, arthralgia, weakness, malaise, respiratory distress, pneumonia, 
enlargement of liver and spleen, fever, thrombocytopenia, late neonatal hyperbili-
rubinemia, and septicoemia. The diagnosis of brucellosis was based on a positive 
blood culture (isolation Brucella of blood culture from both the mother and the 
neonate or only neonate) and on a high or rising titer of antibodies to the Brucella 
organism (positive serology only in the mother or both). The neonates with 
negative Brucella serology may also have Brucella infection. The mortality rate is 
very high, and infected neonates need early detection and timely treatment. Early 
detection and treatment reduce the incidence of complications. The treatment of 
rifampicin and trimethoprim/sulfamethoxazole is useful for neonatal brucellosis. 
More patients with neonatal brucellosis well respond to antibiotic therapy and 
must monitor by a Brucella titer of <1:40.
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1. Introduction
Brucellosis is one of the most widespread zoonoses world [1, 2]. It is an acute or 
chronic zoonotic infection usually transmitted to humans through direct contact 
with infected animals or by eating contaminated food from infected animals (cat-
tle, sheep, goats, pigs, or another animals) or food products such as unpasteurized 
milk, cheese or inhalation of contaminated air or dust particles and exposure is fre-
quently occupational [1–4]. The prevalence of brucellosis has been increasing due 
to growing international tourism and migration of peoples [5, 6]. It is an important 
cause of economic loss and public health problems and is one of the important 
human infections in many developing countries or parts of the world. Brucellosis 
affects humans in all age groups and both genders with variable incidence accord-
ing to the geographic location and the strain [1–43]. Although this disease is now 
uncommon in the United States and Britain but common in the Latin America, 
Africa, Mediterranean and Persian Gulf regions and parts of Asia specially in Iran 
[1–8, 32, 39]. Brucellosis has high morbidity both for animals or humans and one of 
the causes of abortion in animals but in humans it causes multisystem disease [1–8, 
44]. Brucellosis is not uncommon in many parts of the world but human-to-human 
transmission, for example, through sexual intercourse, mother to newborn is rare, 
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but possible and has been reported [9–11]. Vertical transmission from mother to 
fetus during pregnancy (transplacental) or perinatal exposure has been reported 
[7, 8, 12, 13, 16–18, 25, 44]. Other modes of human-to-human transmission of bru-
cellosis include blood transfusion, bone marrow transplantation and breastfeeding 
[20–25]. Although few cases of perinatal brucellosis have been reported but the 
mode of transmission of Brucella from the mother to the baby remains uncertain.
2. Neonatal brucellosis
Brucellosis is a primarily zoonotic infection, public health problem and seri-
ous threat for people living in endemic areas of world which is caused by Gram-
negative, intracellular, non-spore-forming, non-capsulated, aerobic, nonmotile 
Coccobacilli [1, 26–41]. Brucella melitensis is the most important species for human 
brucellosis, but other species, including B. abortus, B. suis, B. canis, and B. novel 
marine have also been associated with human cases [1–3, 26, 29, 32, 43]. Brucellosis 
can be transmitted to humans from direct contact by infected animals, products 
of conception, or animal discharge, and by consumption of infected milk, milk 
products or meat [2, 3, 5, 26, 32, 43]. Human-to-human transmission is rare, but has 
been reported in association with blood transfusions, bone marrow transplanta-
tion, trans placental or perinatal exposure and possibly postnatally by consumption 
breast feeding [7, 8, 12, 13, 16–18, 20–25, 44].
Neonatal brucellosis is rare and there are only a few reports of congenital 
brucellosis [7, 8, 12–14, 17, 43, 44]. There are few data supporting transmission from 
mother to fetus or transmission via breast milk [7, 8, 12, 13, 16–18, 23, 25]. It seems 
that in most cases Brucella passes through the placenta. Transplacental and con-
sumption breast milk are the main routes of Brucella transmission in mammalian 
reservoirs [7, 8, 12, 13, 23–25]. Ingestion of maternal blood, urine or feces during 
delivery might be another rout of Brucella transmission [10, 14, 19].
Although infected pregnant animals transfer Brucella to their offspring transpla-
centally with resultant massive wastage of conception, this mode of transmission 
and resultant interference with the normal course of pregnancy has been disputed 
in humans [2, 32, 43].
Neonatal brucellosis is a very rare cause of early onset neonatal sepsis but 
should be considered in neonates born from mothers at risk for brucellosis [7–10]. 
Physicians dealing with mothers who lived in endemic areas during pregnancy 
should maintain a large index of suspicion when these mothers present with unex-
plained symptoms, especially for those with social and occupational risk for brucel-
losis because as soon as diagnosis and therapy can lead to good and better outcome. 
Education for pregnant women living in endemic areas for avoidance of exposure 
to sheep, goat, camels and do not consumption of unpasteurized products is most 
important and highly recommended. Family history of brucellosis or exposure must 
be obtained during prenatal care in endemic areas [1, 38, 39]. Sometimes maternal 
brucellosis lead to preterm delivery and with adverse long-term outcomes [16]. 
Transplacental transmissions from an infected mother, exposure to maternal blood, 
urine, or genital secretions during delivery are the main routes of transmission of 
neonatal brucellosis [10, 14, 19].
Pregnancy caused to impaired immunological status, and infection with 
Brucella can deformation obstetric outcomes, including congenital infection [44, 
45]. At one point it was believed that adverse pregnancy outcomes associated with 
human brucellosis should be uncommon due to the absence of erythritol in the 
human placenta [46, 47]. Another theory was that amniotic fluid contains anti-
Brucella activity [48]. However, many reports describe apparent increased rates of 
3Neonatal Brucellosis
DOI: http://dx.doi.org/10.5772/intechopen.86703
spontaneous abortion, intrauterine fetal death, and preterm birth in mothers with 
brucellosis during pregnancy [49]. Recognition and suitable treatment of infection 
in early course of pregnancy lead to decrease of incidence of spontaneous abortion, 
intrauterine fetal death, and congenital infection [44, 46–49]. The clinical manifes-
tations of brucellosis in pregnancy are similar to other infected people and include 
arthralgia, arthritis, fever, chills, sweating, headache, malaise, nausea, vomiting, 
lymphadenopathy, hepatosplenomegaly, anorexia and weight loss [1–3, 45–47]. 
Positive blood or bone marrow culture are definite diagnosis but serologic tests 
(Wright and 2-mercapto ethanol, 2ME) are the commonest diagnostic methods 
[1, 3, 45–47].
The choice treatment for brucellosis in infected mother during pregnancy is a 
combination of rifampin and trimethoprim-sulfamethoxazole but trimethoprim-
sulfamethoxazole is contraindicated in first trimester and the last 2–4 weeks of 
pregnancy. During the third generation and first trimester of pregnancy, cephalo-
sporins have been used and in the last month of pregnancy, combination of amino-
glycosides (gentamycin) with rifampin is an alternative regimen [33, 39, 45–49].
3. Clinical manifestations
Newborns with symptom onset in the first week of life have presumably con-
genital brucellosis, although the incubation period of Brucella in newborn period 
can vary from less 1 week to 1 months (typically 2–4 weeks) [50]. Delayed diag-
nosis of congenital brucellosis in preterm infants can overlap with other diseases 
of prematurity. Term infants with onset of symptoms beyond 1 week of age may 
have acquired Brucella through breastfeeding or ingestion of nonhuman milk but 
congenital infection can also have a delayed presentation [9]. The neonatal immune 
system is immature, the response to well-characterized infective processes var-
ies from that described in older children and hence clinical manifestations may 
differ. Differential diagnosis between other bacterial infections in the newborn 
and brucellosis is difficult and presentations of brucellosis in the neonate are 
nonspecific and it is very difficult to distinguish brucellosis clinically from other 
bacterial infections. Fever, arthralgia, night sweating, anemia, bone marrow failure, 
jaundice, respiratory distress, vomiting, irritability, seizure, hepatosplenomegaly, 
dearie, skin rash, nausea, vomiting, malaise, poor feeding, failure to thrive (FTT) 
and distended abdomen are probable signs and symptoms in neonatal brucellosis 
[48]. The role of Brucella in myocarditis and hydrocephalus is difficult to determine 
both reported from neonates who acquired Brucella from breast milk [51, 52]. In 
summary, brucellosis should be considered as a possible cause of early or late onset 
sepsis in newborns presenting with fever, respiratory distress and hepatospleno-
megaly in endemic regions [53].
4. Diagnosis
Hematological and biochemical tests used in neonatal sepsis are of limited value 
for the diagnosis of brucellosis [17, 18]. In brucellosis, the white blood cell count is 
often normal or low. In neonates suspect to brucellosis, the diagnosis was made by 
the unexpected isolation of Brucella from blood culture obtained from a sick neo-
nate with suspected sepsis. Serologic tests are also important methods for clinical 
diagnosis but should be interpreted judiciously because of transplacental passage 
of maternal IgG antibodies [54]. A negative serologic test should never exclude the 
diagnosis, particularly in preterm neonates who may not have mounted their own 
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antibody response nor received transplacental antibodies. For further evaluation, 
blood should be sent for nested PCR and DNA sequencing. Definite diagnosis in 
neonates could be verified based on separating etiologic agent since maternal IgG 
exists in infant serum till 6 months after delivery [7–9, 17, 18, 54].
5. Treatment
Tetracycline or doxycycline with streptomycin or gentamicin are recommended 
therapies in older children or adults [39, 55]. Quinolones and doxycycline are some-
times used for treatment of brucellosis in adolescents but their safety in infants 
and newborns has not been established [32, 33]. Because of the side effects of 
tetracycline and doxycycline in children younger than 10 years of age, a variety of 
drugs can be used safely, for example a combination of rifampin and trimethoprim-
sulfamethoxazole [32, 33, 43, 55].
The combination of intravenous aminoglycosides for 5–7 days plus with rifampicin 
and trimethoprim-sulfamethoxazole orally 6–8 weeks is a commonly regimen and has 
been suggested as the treatment of choice for neonatal brucellosis [7, 8, 12, 13, 56].
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